Sleven, the buyback and every other "action" taken by management has been a con. I mean what the hell was that investor conference? I didn't need someone to tell me how great the drug is. I need someone to tell me how they are going to make money. At this point, what is the plan? They just had an investor conference and I have no idea. They are really just going thru the day to day motions of running a business. It's all reactionary and robotic. Kind of reminds me of the last 4 years.
Market Data 
Markets 
AI
